Cistron Biotechnology(CIST)$.30 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Harmon who wrote (1174)	6/18/1998 4:36:00 PM
From: Rudy Saucillo	Read Replies (1) of 2742

<<I am certain of the next two statements: 1)Smithkline has a interest in the results of Cistron's flu vaccine study with Novavax.>> Steve, Graphical results of the Cistron/Novavax study presented last Nov. are shown on CIST's website. It's sort of hidden, so I would guess not everyone has seen this. Go to cistronbio.com and scroll to the bottom of the page. Very impressive results. After the boost injection, anti-flu titer with Novasome/flu/IL-1b is roughly 10x higher than flu alone. I agree with you. Smithkline and other vaccine developers should be interested in this technology. So why hasn't this been partnered??? Rudy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next